Found 11 matching trials
Study Where Pharmaco Magnetic Resonance Imaging (MRI) Effects of AZD6765 Will be Compared to Placebo in Depressive Male and Female Subjects
PHASE1The purpose of this study is to determine the effect of a single dose infus...
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
PHASE2The purpose of this study is to assess the effect and safety of AZD6765 in ...
A Study in Healthy Volunteers to Assess Effect of AZD6765 on Midazolam Blood Levels
PHASE1The main purpose of this study is to evaluate the effect repeated doses of ...
NMDA Receptor Modulation for Hyperarousal in PTSD
PHASE1This Phase 1b study examines the safety and efficacy of parenterally-admini...
Location
Michael E. DeBakey VA Medical Center
AZD6765 Oral Single Ascending Dose/Multiple Ascending Dose (SAD/MAD)
PHASE1The purpose of this study is to determine the safety of AZD6765 when given ...
AZD6765 Severe Major Depressive Disorder (MDD) IV
PHASE2The purpose of this research study is to determine whether AZD6765 has an e...
This is a Study to Determine the Antidepressant Effects of AZD6765
PHASE2The purpose of this study is to determine the antidepressant effects of AZD...
AZD6765 for Treatment Resistant Depression
PHASE2The purpose of this study is to determine whether treatment with AZD6765 wi...
A Blinded, Four-Way Crossover in Healthy Subjects to Assess EEG After Administration of Ketamine, Placebo and AZD6765
PHASE1This study will provide data to support preclinical to clinical translation...
AZD6765 Single and Multiple Ascending Dose Study in Healthy Male and Female Japanese and Caucasian Subjects
PHASE1This is a Phase I randomized double-blind, placebo-controlled, single and m...